Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (1593)	1/15/2005 12:52:41 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 12215

Buffalo Springfield?

To: quidditch who wrote (1593)	1/15/2005 3:17:58 PM
From: scaram(o)uche	Respond to of 12215

>> had I medicated with mygn, I'd feel mo better momo << Yeah, it's always great to have a runner while other cheap stuff is getting beaten on. A few years ago -- post-9/11 -- it became popular to bail from/short small biotechs during H&Q and after "January effect". I didn't think it would dent the sector this year. Wrong again. There are too many fund managers out there now who use seasonal trading dogma to make money....... sell biotechs, second week of January and in May. Rally them late February to May and September to year end. It's no longer possible to push against this garbage. You either have to play along, sit it out, or pray for luck. Yes, it's good to be overweight stocks that are going up while others are taking an irrational hit. Luck carries the day, again.